Organization

Unity Biotechnology

About

Unity Biotechnology is a biotechnology and frontier medicine company with a mission to develop a new class of therapeutics to reduce, eliminate, or reverse aging diseases. Their mission to extend lifespan without the burden of disease starts with an initial focus to eliminate or better control senescent cells. Thereby providing direct transformative change in age related ophthalmologic and neurologic diseases with specific therapy including diabetic macular edema and age related macular degeneration.

Overview

Founded 2011
Type Public
Location San Francisco, California, USA

Stock

UBX $0.41 0.34% $0.00

Latest News

Bears are Losing Control Over UNITY Biotechnology, Inc. (UBX), Here's Why It's a 'Buy' Now Aug 30, 2022 Zacks Investment Research UNITY Biotechnology, Inc. (UBX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition...
This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday Aug 19, 2022 Benzinga Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday. Plus Therapeutics, Inc. (NASDAQ: PSTV) shares climbed 53.9% to...
Dow Falls 60 Points; Crude Oil Rises Sharply Aug 18, 2022 Benzinga U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 60 points on Thursday. The Dow traded down 0.19% to...
Why Plus Therapeutics Is Trading Higher By Over 50%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session Aug 18, 2022 Benzinga Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 297% to $3.66. Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) shares rose 50.9% to $1.1299 amid mention...
U.S. Stocks Turn Higher; Nasdaq Rises 50 Points Aug 18, 2022 Benzinga U.S. stocks turned higher midway through trading, with the Nasdaq Composite gaining 50 points on Thursday. The Dow traded up 0.02% to 33,988.56 while the...